Virginia Regulatory Town Hall

Guidance Documents in Effect

  Search Options
Symbol Legend
Blue Symbol Proposed change submitted for Governor's Office review
Grey Symbol Forum not yet submitted for publication
Orange Symbol Forum submitted for publication, but not yet open
Green Symbol Forum is open for comments
Purple Symbol Forum closed, changes not yet updated by the agency
Agency
Department of Health Professions
Board
Board of Pharmacy
Chapter
Regulations Governing Collaborative Practice Agreements [18 VAC 110 ‑ 40]
69 guidance documents relevant to this chapter for the criteria specified
 

ID Title Effective Date  
Agency level documents applying to all of this agency's boards
76-10.01 Delegation to agency subordinates 10/13/2022 
76-10.02 Providing Sanction Reference Point worksheets to Respondents 5/3/2018 
76-10.03 Subpoenas for Disciplinary Hearings 12/22/2022 
76-10.05 Reports to The Data Bank 1/5/2023 
76-10.06 Disciplinary process for cases involving non-compliance with section 54.1-2400.6 1/5/2023 
76-10.12 Participation of adjudication specialists in closed sessions 8/9/2017 
76-10.17 Publication of Notices and Orders on the Department websites 1/5/2023 
76-10.24 Summary suspensions and restrictions 3/6/2018 
76-20 Adjudication Manual - Disciplinary process 11/10/2022 
76-20.01 Communication with the media 5/15/2018 
76-20.04 Disclosure of non-investigative information by the Department 1/5/2023 
76-20.05 Disclosure of Information to Health Practitioner Monitoring Program 1/5/2023 
76-30.2 Procurement of professional services 1/5/2023 
76-34 Reporting by Hospitals and Other Health Care Institutions 9/16/2021 
76-35 Virginia Freedom of Information Act Requests 9/1/2022 
76-39 Guidelines for Pro Hac Vice practice 12/14/2017 
76-40.01 Receipt and investigation of allegations of misconduct 1/5/2023 
76-40.02 Unlicensed activity 1/5/2023 
76-40.05 Diciplinary cases involving board members 1/5/2023 
76-80.12 Extension of time for active duty service members or spouses 1/5/2023 
76-90.01 Prescription Drug Monitoring Advisory Committee 5/4/2018 
76-90.02 Custodians of records 1/5/2023 
76-90.03 Foreign applicants and social security numbers 12/8/2022 
76-90.05 Principles/Establishment of Fees 1/5/2023 
BOARD: Board of Pharmacy
110-1 List of categories of facility licenses and a brief description of each 1/4/2024 
110-10 Dispensing drugs from a mobile van 2/2/2023 
110-11 Proof of identity for schedule II drugs 2/2/2023 
110-12 Bylaws of the Board of Pharmacy 11/12/2020 
110-13 Guidance on use of collaborative agreements 1/4/2024 
110-15 Delegation of authority for disciplinary action to the executive director of the Board 2/6/2020 
110-16 Performing inventories 8/6/2020 
110-17 Instructions for graduates of foreign schools of pharmacy 8/5/2021 
110-18 Advance preparation for administration 12/9/2019 
110-19 Use of automated dispensing devices in certain facilities 11/25/2021 
110-2 Instructions for applicants for Pharmacist Licensure 8/5/2021 
110-21 Sanction Reference Manual 12/10/2018 
110-22 Dispensing records; identification of pharmacist 8/6/2020 
110-23 Inspection deficiency monetary penalty guide for physicians selling drugs 2/6/2020 
110-24 Guidance for setting NAPLEX passing score 2/2/2023 
110-25 Guidance for life of a prescription after a prescriber no longer in practice 10/27/2022 
110-26 Pharmacy Working Conditions 5/12/2022 
110-27 Pharmacist-In-Charge responsibilities 5/27/2021 
110-28 Guidance for free clinic pharmacy permit applicants 2/2/2023 
110-29 Guidance document for practitioners dispensing 1/4/2024 
110-3 Guidance on alternative delivery of prescriptions, pharmacy to physician or pharmacy to controlled substance registrant 9/16/2021 
110-30 Drugs within animal shelters 11/25/2021 
110-31 Approved capture drugs and drug administering equipment, Directive from the State Veterinarian 11/25/2021 
110-32 Cannabis: Potential Drug Interactions 8/4/2022 
110-33 Pharmacy Interns as Pharmacy Technicians; Pharmacy Technician Ratio 11/26/2022 
110-34 Manufacturer and wholesale distributor license 11/25/2021 
110-35 Requirements for Prescriptions 1/4/2024 
110-36 Compliance with USP Standards for Compounding 1/4/2024 
110-37 Access to Prescriptions During Unanticipated Shortened Hours 6/8/2023 
110-38 Requirement for Non-resident Pharmacies to Submit Inspection Report 3/30/2021 
110-39 Hours of continuous work and breaks for pharmacists 2/4/2021 
110-4 Continuing Education Guide for Pharmacists 3/18/2021 
110-41 Guidance on Emergency Medical Services Drug Kits 11/25/2021 
110-42 Continuing education audit and recommended sanctions 2/3/2022 
110-43 Dispensing with an authorized generic 2/2/2023 
110-44 Protocol for the Prescribing and Dispensing of Naloxone 1/4/2024 
110-46 Delivery of dispensed drugs 1/4/2024 
110-47 Provision of counseling and information by pharmacists on proper drug disposal 2/2/2023 
110-49 Credentials for Nonresident Pharmacy Dispensing only for Animals 8/6/2020 
110-5 Instructions and forms for reporting of thefts or losses of drugs 11/25/2021 
110-50 Pharmacy Administration Records 6/8/2023 
110-6 Guidance for pharmacies within opioid treatment programs 10/27/2022 
110-7 Practitioner/patient relationship and the prescribing of drugs for family or self 1/4/2024 
110-8 Information on prescriptive authority in Virginia 1/4/2024 
110-9 Pharmacy Inspection Deficiency Monetary Penalty Guide 3/28/2024 
spacer

Documents listed are for the parent board or agency since they may be relevant to this chapter. No guidance documents apply to this chapter specifically.